These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 19479860

  • 21. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP.
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [Abstract] [Full Text] [Related]

  • 22. Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.
    Mina-Osorio P, LaStant J, Keirstead N, Whittard T, Ayala J, Stefanova S, Garrido R, Dimaano N, Hilton H, Giron M, Lau KY, Hang J, Postelnek J, Kim Y, Min S, Patel A, Woods J, Ramanujam M, DeMartino J, Narula S, Xu D.
    Arthritis Rheum; 2013 Sep; 65(9):2380-91. PubMed ID: 23754328
    [Abstract] [Full Text] [Related]

  • 23. Genetic susceptibility to polyI:C-induced IFNalpha/beta-dependent accelerated disease in lupus-prone mice.
    Jørgensen TN, Thurman J, Izui S, Falta MT, Metzger TE, Flannery SA, Kappler J, Marrack P, Kotzin BL.
    Genes Immun; 2006 Oct; 7(7):555-67. PubMed ID: 16900204
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Therapeutic effect of early thymic irradiation in (NZB x NZW)F1 mice, associated with a selective decrease in the levels of IgG3 and gp70-anti-gp70 immune complexes.
    Erausquin C, Merino R, Izui S, Fernandez-Sueiro L, Saez F, Fernandez F, Rodriguez-Valverde V, Merino J.
    Cell Immunol; 1995 Apr 01; 161(2):207-12. PubMed ID: 7697731
    [Abstract] [Full Text] [Related]

  • 26. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ, Weaver CT, McCrory MA, van Ginkel FW, Reiman RM, Kearney JF, Marion TN, Volanakis JE.
    Arthritis Rheum; 2003 Jun 01; 48(6):1602-11. PubMed ID: 12794828
    [Abstract] [Full Text] [Related]

  • 27. Galectin-1-induced down-regulation of T lymphocyte activation protects (NZB x NZW) F1 mice from lupus-like disease.
    Liu SD, Lee S, La Cava A, Motran CC, Hahn BH, Miceli MC.
    Lupus; 2011 Apr 01; 20(5):473-84. PubMed ID: 21335401
    [Abstract] [Full Text] [Related]

  • 28. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice.
    Reilly CM, Thomas M, Gogal R, Olgun S, Santo A, Sodhi R, Samy ET, Peng SL, Gilkeson GS, Mishra N.
    J Autoimmun; 2008 Sep 01; 31(2):123-30. PubMed ID: 18650065
    [Abstract] [Full Text] [Related]

  • 29. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
    Borel Y, Lewis RM, André-Schwartz J, Stollar BD, Diener E.
    J Clin Invest; 1978 Feb 01; 61(2):276-86. PubMed ID: 304453
    [Abstract] [Full Text] [Related]

  • 30. Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients.
    Mauermann N, Sthoeger Z, Zinger H, Mozes E.
    Clin Exp Immunol; 2004 Sep 01; 137(3):513-20. PubMed ID: 15320900
    [Abstract] [Full Text] [Related]

  • 31. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H, Terada E, Okudaira K.
    Prog Clin Biol Res; 1987 Sep 01; 229():157-74. PubMed ID: 3601985
    [Abstract] [Full Text] [Related]

  • 32. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice.
    Viau M, Zouali M.
    Mol Immunol; 2005 May 01; 42(7):849-55. PubMed ID: 15829273
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
    Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S, Chang B, Zhao FF, Payan DG, Grossbard EB, Daikh DI.
    Arthritis Rheum; 2008 May 01; 58(5):1433-44. PubMed ID: 18438845
    [Abstract] [Full Text] [Related]

  • 35. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
    Song YW, Tsao BP, Hahn BH.
    J Autoimmun; 1993 Feb 01; 6(1):1-9. PubMed ID: 8457281
    [Abstract] [Full Text] [Related]

  • 36. Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA.
    Portanova JP, Claman HN, Kotzin BL.
    J Immunol; 1985 Dec 01; 135(6):3850-6. PubMed ID: 3877758
    [Abstract] [Full Text] [Related]

  • 37. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ, Minh MG, Mignon-Conte MA, Hass S, Lambert PH, Conte JJ.
    J Clin Lab Immunol; 1980 Sep 01; 4(2):103-6. PubMed ID: 7441709
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Murine lupus nephritis. Effects of glucocorticoid on circulating and tissue-bound immunoreactants.
    Cavallo T, Graves K, Granholm NA.
    Lab Invest; 1983 Oct 01; 49(4):476-81. PubMed ID: 6604840
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.